Clinical Trial Update: Clinical Study of Glaukos® Trabecular Micro-Bypass System Model iS3 Infinite Vs. Competitor [NA]

View source ↗

Summary

An ongoing clinical trial compares the Glaukos Trabecular Micro-Bypass System iS3 Infinite against a competitor for open-angle glaucoma and is currently active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Open-angle Glaucoma

Drugs mentioned

• Glaukos Trabecular Micro-Bypass System iS3 Infinite

Snippet

Sponsor: Glaukos Corporation | Conditions: Glaucoma, Glaucoma, Open-Angle | NA | Status: ACTIVE_NOT_RECRUITING